Skip to main content

Table 4 Number of lines of subsequent systemic treatments

From: The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole

Number of treatments Tamoxifen patients Letrozole patients
0 (n = 47) 22 25
1 (n = 28) 13 15
2 (n = 16) 6 10
3 (n = 4) 0 4
4 (n = 2) 2 0